AI assistant
Sending…
Anterix Inc. — Director's Dealing 2025
Nov 5, 2025
33018_dirs_2025-11-04_1e6079fc-dc38-41d2-bf60-2d28cc708e7d.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: Anterix Inc. (ATEX)
CIK: 0001304492
Period of Report: 2025-09-22
Reporting Person: Marquez Elena (Chief Financial Officer)
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 7028 | Direct |
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Stock Option (Right to Buy) | $40 | 2035-04-03 | Common Stock (3680) | Direct |
Footnotes
F1: Includes Restricted Stock Units in the amount (i) 877 shares vesting on May 15, 2026; (ii) 672 shares vesting on July 12, 2026; and (iii) 3,925 shares vesting in 3 equal annual installments beginning on October 4, 2025.
F2: The option shares vest and become exercisable in 3 equal annual installments beginning on October 4, 2025.
More from Anterix Inc.
Regulatory Filings
2026
Apr 21
Regulatory Filings
2026
Apr 21
Regulatory Filings
2026
Apr 6
Regulatory Filings
2026
Apr 1
Regulatory Filings
2026
Feb 11
Interim / Quarterly Report
2026
Feb 11
Regulatory Filings
2026
Feb 2
Major Shareholding Notification
2026
Jan 30
Regulatory Filings
2026
Jan 7
Director's Dealing
2025
Dec 19